B. Garner

发表

Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells

C. Lim, W. Kim, G. Guillemin, 2006, Neuroreport.

Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease

C. Weickert, W. Kim, B. Garner, 2008, Journal of neurochemistry.

Structural Elucidation of the N- andO-Glycans of Human Apolipoprotein(a)

P. Rudd, B. Garner, D. Harvey, 2001, The Journal of Biological Chemistry.

Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease

G. Halliday, B. Garner, J. Wong, 2012, Neuroscience.

Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions

Hongyun Li, B. Garner, T. Karl, 2016, PloS one.

Oxidation of High Density Lipoproteins

M. Raftery, R. Stocker, P. Witting, 1998, The Journal of Biological Chemistry.

Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.

R. Stocker, B. Garner, B. Garner, 1994, The Journal of clinical investigation.

Characterization of the Kynurenine Pathway in Human Neurons

Gilles J Guillemin, Bruce J Brew, B. Brew, 2007, The Journal of Neuroscience.

The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis

V. Meininger, B. Brew, G. Guillemin, 2010, Neurotoxicity Research.

Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6/1 Huntington's Disease Mice.

A. Hannan, B. Garner, A. Jenner, 2016, Journal of Huntington's disease.

Apolipoprotein‐D expression is increased during development and maturation of the human prefrontal cortex

M. Webster, C. Weickert, S. Bahn, 2009, Journal of neurochemistry.

High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide.

R. Dwek, B. Garner, F. Platt, 2001, Analytical biochemistry.

Oxidation of High Density Lipoproteins

R. Stocker, P. Witting, K. Rye, 1998, The Journal of Biological Chemistry.

Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles.

P. Rudd, B. Garner, D. Harvey, 2001, Glycobiology.

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

B. Garner, David Cheng, J. Arnold, 2012, Expert opinion on therapeutic targets.

Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue

B. Garner, A. Jenner, C. Mclean, 2016, Neuropathology and applied neurobiology.

Perturbation of neuronal cobalamin transport by lysosomal enzyme inhibition

Hongyun Li, B. Garner, K. Ruberu, 2014, Bioscience reports.

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.

R. Stocker, B. Garner, D. Priestman, 2002, Journal of lipid research.

Sensitivity to Lysosome-Dependent Cell Death Is Directly Regulated by Lysosomal Cholesterol Content

P. Saftig, B. Garner, K. Öllinger, 2012, PloS one.

Metal Reduction By Macrophages

R. Dean, B. Garner, W. Jessup, 1998 .

Direct Copper Reduction by Macrophages

R. Dean, B. Garner, W. Jessup, 1997, The Journal of Biological Chemistry.

Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway

I. Gelissen, W. Kim, E. Glaros, 2005, Journal of Biological Chemistry.

B. Garner, U. Brunk, Hua Zhao, 2011, Cellular and Molecular Life Sciences.

Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis.

B. Garner, U. Brunk, W. Jessup, 2004, The Biochemical journal.

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.

R. Dwek, B. Garner, F. Platt, 2002, Biochemical and biophysical research communications.

Heterogeneous expression of apolipoprotein‐E by human macrophages

E. Glaros, B. Garner, U. Brunk, 2004, Immunology.

Alanine metabolism, transport, and cycling in the brain

A. Bröer, S. Bröer, W. Bubb, 2007, Journal of neurochemistry.

Cognitive phenotyping of amyloid precursor protein transgenic J20 mice

W. Kim, B. Garner, David Cheng, 2012, Behavioural Brain Research.

Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.

A. Hannan, B. Garner, A. Jenner, 2015, Journal of Huntington's disease.

Investigation of the lipid component of neuromelanin

P. Riederer, K. Double, G. Halliday, 2006, Journal of neural transmission.

Dolichol is the major lipid component of human substantia nigra neuromelanin

P. Riederer, K. Double, G. Halliday, 2005, Journal of neurochemistry.

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice

B. Garner, J. K. Low, David Cheng, 2014, Psychopharmacology.

Evidence that truncated TrkB isoform, TrkB-Shc can regulate phosphorylated TrkB protein levels.

B. Garner, J. Wong, 2012, Biochemical and biophysical research communications.

Cell-mediated oxidation of low-density lipoprotein: the elusive mechanism(s).

B. Garner, W. Jessup, 1996, Redox report : communications in free radical research.

Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex

G. Halliday, M. Wenk, W. Kim, 2011, PloS one.

Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition

W. Kim, E. Glaros, B. Garner, 2010, Clinical science.

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

G. Halliday, A. Cooper, E. Sidransky, 2014, Brain : a journal of neurology.

Impaired lysosomal cobalamin transport in Alzheimer's disease.

Hongyun Li, B. Garner, K. Ruberu, 2014, Journal of Alzheimer's disease : JAD.

Human Lens Coloration and Aging

R. Truscott, B. Garner, B. Garner, 1999, The Journal of Biological Chemistry.

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice

B. Garner, J. K. Low, David Cheng, 2014, Psychopharmacology.

Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains.

J. W. Wong, B. Garner, Diako Ebrahimi, 2011, The Biochemical journal.

Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

G. Halliday, A. Cooper, B. Garner, 2015, Movement disorders : official journal of the Movement Disorder Society.

Apolipoproteins in the brain: implications for neurological and psychiatric disorders

D. Elliott, B. Garner, C. Weickert, 2010, Clinical lipidology.

Vascular pharmacotherapy and dementia.

O. Piguet, B. Garner, 2010, Current vascular pharmacology.

Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice

A. Ittner, B. Garner, L. Ittner, 2020, Pharmacology, Biochemistry and Behavior.

Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ42 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice.

B. Garner, T. Karl, Juan C Olaya, 2020, Journal of Alzheimer's disease : JAD.

Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.

P. Schofield, J. Kwok, M. Hallupp, 2018, Journal of Alzheimer's disease : JAD.

Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO)

C. Rae, B. Garner, G. Ball, 2008, Journal of neuroscience research.

Wnt is here! Could Wnt signalling be promoted to protect against Alzheimer disease?

B. Garner, L. Ooi, 2018, Journal of neurochemistry.

TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer ' s disease

G. Halliday, J. Kwok, B. Garner, 2016 .

The comparative biology of neuromelanin and lipofuscin in the human brain

K. Double, G. Halliday, B. Garner, 2008, Cellular and Molecular Life Sciences.

Srp20 regulates TrkB pre‐mRNA splicing to generate TrkB‐Shc transcripts with implications for Alzheimer’s disease

G. Halliday, J. Kwok, B. Garner, 2012, Journal of neurochemistry.

Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease.

G. Halliday, W. Kim, B. Garner, 2010, Biochimica et biophysica acta.

Identification of a novel tetrameric structure for human apolipoprotein-D

B. Garner, A. Oakley, A. Whitten, 2018, bioRxiv.

Identification of a novel tetrameric structure for human apolipoprotein-D

B. Garner, A. Oakley, A. Whitten, 2018, bioRxiv.

Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mices⃞ Published, JLR Papers in Press, October 31, 2007.

K. Rye, E. Glaros, B. Garner, 2008, Journal of Lipid Research.

The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis

A. Saghatelian, Hongyun Li, B. Garner, 2018, The Journal of Biological Chemistry.

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.

B. Garner, David Cheng, T. Karl, 2017, Behavioural pharmacology.

Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons.

D. Elliott, G. Halliday, W. Kim, 2010, Journal of Alzheimer's disease : JAD.

Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance.

P. Rudd, B. Garner, D. Harvey, 2001, The Journal of biological chemistry.

Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice

Diego Sanchez, Maria D. Ganfornina, Kalani Ruberu, 2015, Neurobiology of Aging.

Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues

A. Hill, A. Bush, G. Evin, 2011, Clinical science.

Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity.

M. Freeman, A. Hill, G. Evin, 2011, Journal of Alzheimer's disease : JAD.

Modulation of amyloid precursor protein processing by synthetic ceramide analogues.

A. Hill, G. Evin, Hongyun Li, 2010, Biochimica et biophysica acta.

ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro

A. Hill, J. Kwok, R. Cappai, 2008, Journal of neurochemistry.

Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation*

A. Hill, I. Gelissen, K. Rye, 2007, Journal of Biological Chemistry.

Isoform-specific proteolysis of apolipoprotein-E in the brain

D. Elliott, G. Halliday, K. Rye, 2011, Neurobiology of Aging.

Understanding the Role of ApoE Fragments in Alzheimer’s Disease

B. Garner, L. Ooi, S. S. Muñoz, 2018, Neurochemical Research.

Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches.

D. Elliott, K. Rye, W. Kim, 2008, The Biochemical journal.

Macrophage apolipoprotein-E knockdown modulates caspase-3 activation without altering sensitivity to apoptosis.

D. Elliott, W. Kim, B. Garner, 2008, Biochimica et biophysica acta.

Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease

L. Quek, T. Fath, N. Turner, 2016, Neurobiology of Aging.

Molecular Dynamics Analysis of Apolipoprotein-D - Lipid Hydroperoxide Interactions: Mechanism for Selective Oxidation of Met-93

B. Garner, A. Oakley, H. Ecroyd, 2012, PloS one.

Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis

Russell Pickford, Benjamin Daniels, Claire Shepherd, 2014, Acta neuropathologica communications.

Lipids and Alzheimer's disease.

B. Garner, 2010, Biochimica et biophysica acta.

Apolipoprotein-E forms dimers in human frontal cortex and hippocampus

D. Elliott, G. Halliday, B. Garner, 2010, BMC Neuroscience.

Regulation of &agr;-synuclein expression by liver X receptor ligands in vitro

W. Kim, B. Garner, D. Cheng, 2008, Neuroreport.

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.

B. Garner, A. Jenner, David Cheng, 2014, Journal of Alzheimer's disease : JAD.

Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation

B. Garner, K. Öllinger, Andrew J. Brown, 2010, Alzheimer's & Dementia.

Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease.

W. Kim, B. Garner, A. Oakley, 2012, The Biochemical journal.

Apoptosis induces neuronal apolipoprotein-E synthesis and localization in apoptotic bodies

D. Elliott, W. Kim, B. Garner, 2007, Neuroscience Letters.

Cell Type-Specific Modulation of Cobalamin Uptake by Bovine Serum

Hongyun Li, B. Garner, K. Ruberu, 2016, PloS one.

Generation of APOE knock-down SK-N-SH human neuroblastoma cells using CRISPR/Cas9: a novel cellular model relevant to Alzheimer’s disease research

B. Garner, L. Ooi, S. S. Muñoz, 2021, Bioscience reports.

Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease

T. Fath, A. Ittner, G. Guillemin, 2019, The Journal of Neuroscience.

Myriocin as an atherosclerosis inhibitor

B. Garner, 2008 .

Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease

G. Halliday, Hongyun Li, B. Garner, 2014, Movement disorders : official journal of the Movement Disorder Society.

Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons.

A. Hill, W. Kim, G. Guillemin, 2009, Journal of Alzheimer's disease : JAD.

Novel behavioural characteristics of the APP Swe /PS1ΔE9 transgenic mouse model of Alzheimer's disease

B. Garner, David Cheng, T. Karl, 2013, Behavioural Brain Research.

Understanding the function of ABCA7 in Alzheimer's disease.

Hongyun Li, B. Garner, T. Karl, 2015, Biochemical Society transactions.

Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease

D. Elliott, Hongyun Li, W. Kim, 2013, The Journal of Neuroscience.

Lipid content determines aggregation of neuromelanin granules in vitro.

K. Double, G. Halliday, B. Garner, 2007, Journal of neural transmission. Supplementum.

Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression.

R. Dean, B. Garner, W. Jessup, 1997, Atherosclerosis.

Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster

K. Blennow, H. Zetterberg, Hongyun Li, 2016, The FEBS journal.

Small angle X-ray scattering analysis of ligand-bound forms of tetrameric apolipoprotein-D

B. Garner, A. Whitten, Claudia S. Kielkopf, 2020, Bioscience reports.

Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels.

J. Kril, Hongyun Li, B. Garner, 2013, Journal of Alzheimer's disease : JAD.

Human macrophage-mediated oxidation of low-density lipoprotein is delayed and independent of superoxide production.

R. Dean, B. Garner, W. Jessup, 1994, The Biochemical journal.

Deletion of Abca 7 increases cerebral amyloid-β accumulation in the J 20 mouse model of Alzheimer ' s disease

D. Elliott, Hongyun Li, W. Kim, 2017 .

Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease.

G. Halliday, B. Garner, A. Jenner, 2015, Journal of Parkinson's disease.

Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.

G. Halliday, M. Raftery, K. Rye, 2005, Biochemistry.

Novel behavioural characteristics of female APP Swe /PS1ΔE9 double transgenic mice

B. Garner, David Cheng, T. Karl, 2014, Behavioural Brain Research.

Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions

R. Truscott, B. Garner, M. Sheil, 2000, Free radical research.

Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases

W. Kim, B. Garner, R. Chesworth, 2012, PloS one.

Abca7 deletion does not affect adult neurogenesis in the mouse

Hongyun Li, B. Garner, T. Karl, 2016, Bioscience Reports.

Analysis of subcellular [57Co] cobalamin distribution in SH-SY5Y neurons and brain tissue

Hongyun Li, B. Garner, K. Ruberu, 2013, Journal of Neuroscience Methods.

HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation.

B. Garner, L. Kritharides, L. P. Aristoteli, 2006, Biochemical and biophysical research communications.

Distribution of ferritin and redox-active transition metals in normal and cataractous human lenses.

J. Eaton, R. Truscott, B. Garner, 2000, Experimental eye research.

An Improved High-Throughput Lipid Extraction Method for the Analysis of Human Brain Lipids

G. Halliday, B. Garner, T. Mitchell, 2013, Lipids.

Is seladin-1 really a selective Alzheimer's disease indicator?

G. Halliday, B. Garner, Andrew J. Brown, 2012, Journal of Alzheimer's disease : JAD.